Serum syndecan-1 was investigated in 189 patients with newly diagnosed monoclonal proteinemia [the diagnoses were multiple myeloma (66), monoclonal gammopathies of undetermined significance (MGUS; n=54), provisional MGUS (no bone marrow examination performed; n=69)] and 36 controls. Syndecan-1 levels ranged widely between all diagnostic categories and were of limited discriminatory value (sensitivity 68%, specificity 78%) in patients with newly diagnosed monoclonal proteinemia.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
patients newly
12
newly diagnosed
12
diagnosed monoclonal
12
monoclonal proteinemia
12
serum syndecan-1
8
syndecan-1 patients
4
monoclonal
4
proteinemia serum
4
syndecan-1 investigated
4
investigated 189
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!